Dimitrios Paschos

Dimitrios Paschos is a seasoned Consultant Psychiatrist specializing in Intellectual Disabilities, currently employed at Re:Cognition Health Ltd since November 2013, where Dimitrios also serves as Principal Investigator for the V1ADUCT clinical trial studying Balovaptan for Autism Spectrum Disorder. Dimitrios has held critical roles at various organizations, including Clinical Director at the Petra Ecclestone Foundation and Consultant Psychiatrist at Sequence Care Group and Camden & Islington NHS Foundation Trust. Additionally, Dimitrios was an Honorary Research Fellow at King's College London and the Lead Consultant for the Adult ADHD Service at Paschos Medical Consulting Ltd. Dimitrios holds a Medical Degree from Aristotle University of Thessaloniki.